Kimberly Shea

Kim Shea is an infectious disease epidemiologist with a primary interest in vaccine-preventable diseases and global public health. At Pfizer Vaccines, she leads innovative health economics & outcomes research efforts to develop an evidence base supporting COVID-19 and novel maternal vaccine assets. Prior to joining Pfizer, she was an Assistant Professor of Epidemiology at the Boston University School of Public Health where she conducted independent research on vaccine impact, vaccine hesitancy, and antimicrobial resistance.